If this message displays incorrectly, please view the web page |
||||||||||||||||
|
||||||||||||||||
CLINICAL RESEARCH |
||||||||||||||||
PSYCHIATRY Prairie Voles' Consoling Behavior Could Lead to Autism Insights Prairie voles, known for forming lifelong, monogamous bonds, show an empathetic, consoling response when other voles are distressed. The research discovery ends a long-standing belief that detecting the distress of others and acting to relieve it is uniquely human. This knowledge could help medical researchers understand and treat disorders in which emotions are interrupted, such as autism spectrum disorder and schizophrenia. Read more... |
||||||||||||||||
TRANSPLANTATION Emory Researchers Play Key Role in Development of Better Transplant Drug The drug belatacept, which controls the immune system and prevents organ rejection after kidney transplant, was found in seven years of data to have a better record of patient and organ survival than calcineurin inhibitors, the previous standard of care. Belatacept was approved by the FDA in 2011 and has been a game changer for treating kidney transplant patients. Read more... |
||||||||||||||||
PSYCHIATRY Inflammation Biomarkers Could Guide Depression Treatment Some patients with depression may respond better than others to drugs that block glutamate, an inflammation-related brain chemical that can be toxic to brain cells at high levels. Markers of inflammation, such as C-reactive protein, could help guide physicians to predict which depressed patients might respond best to glutamate-blocking drugs. Read more... |
||||||||||||||||
Link to current issue | Archives | More Research News | Contact Us |
||||||||||||||||
Editor, Holly Korschun, Executive Director of Research Communications |
||||||||||||||||